Ischemic Stroke and Cancer: Stroke Severely Impacts Cancer Patients, While Cancer Increases the Number of Strokes

Overview

Journal J Clin Neurol

Specialty Neurology

Date 2011 Jul 23

PMID 21779292

Citations 60

Authors

Oh Young Bang

Jin Myoung Seok

Seon Gyeong Kim

Ji Man Hong

Hahn Young Kim

Jun Lee

Pil-Wook Chung

Kwang-Yeol Park

Gyeong-Moon Kim

Chin-Sang Chung

Kwang Ho Lee

Affiliations

Soon will be listed here.

Abstract

Background: Cancer and ischemic stroke are two of the most common causes of death among the elderly, and associations between them have been reported. However, the main pathomechanisms of stroke in cancer patients are not well known, and can only be established based on accurate knowledge of the characteristics of cancer-related strokes. We review herein recent studies concerning the clinical, laboratory, and radiological features of patients with cancer-related stroke.

Main Contents: This review covers the epidemiology, underlying mechanisms, and acute and preventive treatments for cancer-related stroke. First, the characteristics of stroke (clinical and radiological features) and systemic cancer (type and extent) in patients with cancer-specific stroke are discussed. Second, the role of laboratory tests in the early identification of patients with cancer-specific stroke is discussed. Specifically, serum D-dimer levels (as a marker of a hypercoagulable state) and embolic signals on transcranial Doppler (suggestive of embolic origin) may provide clues regarding changes in the levels of coagulopathy related to cancer and anticoagulation. Finally, strategies for stroke treatment in cancer patients are discussed, emphasizing the importance of preventive strategies (i.e., the use of anticoagulants) over acute revascularization therapy in cancer-related stroke.

Conclusion: Recent studies have revealed that the characteristics of cancer-related stroke are distinct from those of conventional stroke. Our understanding of the characteristics of cancer-related stroke is essential to the correct management of these patients. The studies presented in this review highlight the importance of a personalized approach in treating stroke patients with cancer.

Citing Articles

Tuberculous meningitis-related ischemic stroke: A retrospective study from a tertiary care hospital.

Deng X, Huang Q, Huang H, Chen S, Wang X, Liang Z J Clin Tuberc Other Mycobact Dis. 2025; 38():100508.

PMID: 39802753 PMC: 11720881. DOI: 10.1016/j.jctube.2024.100508.

Caught Between a Rock and a Hard Place: Anticoagulation in Atrial Fibrillation Patients With Cancer.

Shoureshi P, Tan A JACC Adv. 2024; 2(8):100611.

PMID: 38938346 PMC: 11198312. DOI: 10.1016/j.jacadv.2023.100611.

Outcomes and Discriminatory Accuracy of the CHADSVASc Score in Atrial Fibrillation and Cancer.

Ullah W, DiMeglio M, Frisch D, Bagur R, Sun L, Fischman D JACC Adv. 2024; 2(8):100609.

PMID: 38938329 PMC: 11198258. DOI: 10.1016/j.jacadv.2023.100609.

Malignant tumor increases the risk of all causes in-hospital mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database.

Wang Q, Fu W, Wang F BMC Neurol. 2024; 24(1):178.

PMID: 38802785 PMC: 11129437. DOI: 10.1186/s12883-024-03690-4.

Systematic review and meta-analysis of studies comparing baseline D-dimer level in stroke patients with or without cancer: Strength of current evidence.

Mishra R, Chavda V, Moscote-Salazar L, Atallah O, Das S, Janjua T J Neurosci Rural Pract. 2024; 15(1):16-28.

PMID: 38476438 PMC: 10927037. DOI: 10.25259/JNRP_379_2023.

References

Li S, Chen W, Tang Y, Rau K, Chen Y, Huang T . Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg. 2006; 108(2):150-6. DOI: 10.1016/j.clineuro.2005.03.008. View

Singhal A, Topcuoglu M, Buonanno F . Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002; 33(5):1267-73. DOI: 10.1161/01.str.0000015029.91577.36. View

Blackwell K, Hurwitz H, Lieberman G, Novotny W, Snyder S, Dewhirst M . Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer. 2004; 101(1):77-82. DOI: 10.1002/cncr.20336. View

Cestari D, Weine D, Panageas K, Segal A, DeAngelis L . Stroke in patients with cancer: incidence and etiology. Neurology. 2004; 62(11):2025-30. DOI: 10.1212/01.wnl.0000129912.56486.2b. View

Graus F, Rogers L, Posner J . Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985; 64(1):16-35. DOI: 10.1097/00005792-198501000-00002. View

Yu J, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz J . Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2004; 105(4):1734-41. DOI: 10.1182/blood-2004-05-2042. View

Chaturvedi S, Ansell J, Recht L . Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability?. Stroke. 1994; 25(6):1215-8. DOI: 10.1161/01.str.25.6.1215. View

Bang O . Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol. 2009; 5(3):107-19. PMC: 2760715. DOI: 10.3988/jcn.2009.5.3.107. View

Sousou T, Khorana A . New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol. 2009; 29(3):316-20. PMC: 2727713. DOI: 10.1161/ATVBAHA.108.182196. View

10.

Zhang Y, Chan D, Cordato D, Shen Q, Sheng A . Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand. 2006; 114(6):378-83. DOI: 10.1111/j.1600-0404.2006.00709.x. View

11.

Lee A, Levine M, Baker R, Bowden C, Kakkar A, Prins M . Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003; 349(2):146-53. DOI: 10.1056/NEJMoa025313. View

12.

Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak M . Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20(9):1487-95. DOI: 10.1038/sj.leu.2404296. View

13.

Buccheri G, Torchio P, Ferrigno D . Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance. Cancer. 2003; 97(12):3044-52. DOI: 10.1002/cncr.11432. View

14.

Dirix L, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P . Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002; 86(3):389-95. PMC: 2375200. DOI: 10.1038/sj.bjc.6600069. View

15.

Poppert H, Sadikovic S, Sander K, Wolf O, Sander D . Embolic signals in unselected stroke patients: prevalence and diagnostic benefit. Stroke. 2006; 37(8):2039-43. DOI: 10.1161/01.STR.0000231644.47325.aa. View

16.

Bang O, Lee P, Heo K, Joo U, Yoon S, Kim S . Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry. 2005; 76(9):1222-8. PMC: 1739781. DOI: 10.1136/jnnp.2004.059998. View

17.

Kim S, Hong J, Kim H, Lee J, Chung P, Park K . Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010; 41(4):798-801. DOI: 10.1161/STROKEAHA.109.571356. View

18.

Agnelli G, Gussoni G, Bianchini C, Verso M, Mandala M, Cavanna L . Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol. 2009; 10(10):943-9. DOI: 10.1016/S1470-2045(09)70232-3. View

19.

Baird A, Lovblad K, Schlaug G, Edelman R, Warach S . Multiple acute stroke syndrome: marker of embolic disease?. Neurology. 2000; 54(3):674-8. DOI: 10.1212/wnl.54.3.674. View

20.

Mostefai H, Andriantsitohaina R, Martinez M . Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res. 2008; 57(3):311-320. DOI: 10.33549/physiolres.931533. View